Napo Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Napo Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) (NCT06721871) | Napo Pharmaceuticals, Inc. | 2025-05-01 |
| Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy (NCT04538625) | Napo Pharmaceuticals, Inc. | 2020-10-07 |
| Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea (NCT04192487) | Napo Pharmaceuticals, Inc. | 2019-10-22 |
Track Napo Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.